ARCHIVES

Ohio State recruits neurosurgeon from Harvard to lead new department.

This article is from The Cancer Letter archive.

Vol. 30 No. 02 | January 9, 2004

Download PDF Visit The Full Archive

Related Articles

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

Taxol Released On Compassionate Use Basis To Centers; Ohio, Columbia Begin Treatments

October 18, 1991

Improvements Still Needed To Reduce Chemo Errors

November 25, 2005

In Brief: Donaldson, Wilson Lead ASTRO; Thomas To Hear Arguments In Cigarette Case; Doll, Peto Honored

November 8, 1991

Oral Combination Provides Alternative To IV Chemo For Multiple Myeloma

November 29, 2002